Global Bioengineered Protein Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Bioengineered Protein Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Bioengineered Protein Drugs market size is estimated to be worth US$ 86200 million in 2021 and is forecast to a readjusted size of USD 112310 million by 2028 with a CAGR of 3.9% during review period. Cancer accounting for % of the Bioengineered Protein Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal Antibodies segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Bioengineered Protein Drugs include Dr.Reddy’s, Eli Lilly, Merck, Reliance Life Sciences, and Panacea Biotech, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Bioengineered Protein Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Market segment by Application can be divided into
Cancer
Diabetes
Autoimmune Disorder
Infectious Disease
Neurodegenerative
Others
The key market players for global Bioengineered Protein Drugs market are listed below:
Dr.Reddy’s
Eli Lilly
Merck
Reliance Life Sciences
Panacea Biotech
Novartis
Fresenius
Sanofi
ProBioGen
GlaxoSmithKline
Roche
Amoytop Biotech
Shanghai United Cell Biotechnology
Hualan Bio
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bioengineered Protein Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bioengineered Protein Drugs, with price, sales, revenue and global market share of Bioengineered Protein Drugs from 2019 to 2022.
Chapter 3, the Bioengineered Protein Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bioengineered Protein Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Bioengineered Protein Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bioengineered Protein Drugs.
Chapter 13, 14, and 15, to describe Bioengineered Protein Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Bioengineered Protein Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bioengineered Protein Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Monoclonal Antibodies
1.2.3 Therapeutic Proteins
1.2.4 Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Bioengineered Protein Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Autoimmune Disorder
1.3.5 Infectious Disease
1.3.6 Neurodegenerative
1.3.7 Others
1.4 Global Bioengineered Protein Drugs Market Size & Forecast
1.4.1 Global Bioengineered Protein Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Bioengineered Protein Drugs Sales in Volume (2017-2028)
1.4.3 Global Bioengineered Protein Drugs Price (2017-2028)
1.5 Global Bioengineered Protein Drugs Production Capacity Analysis
1.5.1 Global Bioengineered Protein Drugs Total Production Capacity (2017-2028)
1.5.2 Global Bioengineered Protein Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bioengineered Protein Drugs Market Drivers
1.6.2 Bioengineered Protein Drugs Market Restraints
1.6.3 Bioengineered Protein Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Dr.Reddy’s
2.1.1 Dr.Reddy’s Details
2.1.2 Dr.Reddy’s Major Business
2.1.3 Dr.Reddy’s Bioengineered Protein Drugs Product and Services
2.1.4 Dr.Reddy’s Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Bioengineered Protein Drugs Product and Services
2.2.4 Eli Lilly Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Bioengineered Protein Drugs Product and Services
2.3.4 Merck Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Reliance Life Sciences
2.4.1 Reliance Life Sciences Details
2.4.2 Reliance Life Sciences Major Business
2.4.3 Reliance Life Sciences Bioengineered Protein Drugs Product and Services
2.4.4 Reliance Life Sciences Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Panacea Biotech
2.5.1 Panacea Biotech Details
2.5.2 Panacea Biotech Major Business
2.5.3 Panacea Biotech Bioengineered Protein Drugs Product and Services
2.5.4 Panacea Biotech Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Bioengineered Protein Drugs Product and Services
2.6.4 Novartis Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Fresenius
2.7.1 Fresenius Details
2.7.2 Fresenius Major Business
2.7.3 Fresenius Bioengineered Protein Drugs Product and Services
2.7.4 Fresenius Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Bioengineered Protein Drugs Product and Services
2.8.4 Sanofi Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 ProBioGen
2.9.1 ProBioGen Details
2.9.2 ProBioGen Major Business
2.9.3 ProBioGen Bioengineered Protein Drugs Product and Services
2.9.4 ProBioGen Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Bioengineered Protein Drugs Product and Services
2.10.4 GlaxoSmithKline Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Roche
2.11.1 Roche Details
2.11.2 Roche Major Business
2.11.3 Roche Bioengineered Protein Drugs Product and Services
2.11.4 Roche Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Amoytop Biotech
2.12.1 Amoytop Biotech Details
2.12.2 Amoytop Biotech Major Business
2.12.3 Amoytop Biotech Bioengineered Protein Drugs Product and Services
2.12.4 Amoytop Biotech Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Shanghai United Cell Biotechnology
2.13.1 Shanghai United Cell Biotechnology Details
2.13.2 Shanghai United Cell Biotechnology Major Business
2.13.3 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Product and Services
2.13.4 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Hualan Bio
2.14.1 Hualan Bio Details
2.14.2 Hualan Bio Major Business
2.14.3 Hualan Bio Bioengineered Protein Drugs Product and Services
2.14.4 Hualan Bio Bioengineered Protein Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Bioengineered Protein Drugs Breakdown Data by Manufacturer
3.1 Global Bioengineered Protein Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Bioengineered Protein Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Bioengineered Protein Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Bioengineered Protein Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Bioengineered Protein Drugs Manufacturer Market Share in 2021
3.5 Global Bioengineered Protein Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Bioengineered Protein Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bioengineered Protein Drugs Market Size by Region
4.1.1 Global Bioengineered Protein Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Bioengineered Protein Drugs Revenue by Region (2017-2028)
4.2 North America Bioengineered Protein Drugs Revenue (2017-2028)
4.3 Europe Bioengineered Protein Drugs Revenue (2017-2028)
4.4 Asia-Pacific Bioengineered Protein Drugs Revenue (2017-2028)
4.5 South America Bioengineered Protein Drugs Revenue (2017-2028)
4.6 Middle East and Africa Bioengineered Protein Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Bioengineered Protein Drugs Sales in Volume by Type (2017-2028)
5.2 Global Bioengineered Protein Drugs Revenue by Type (2017-2028)
5.3 Global Bioengineered Protein Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Bioengineered Protein Drugs Sales in Volume by Application (2017-2028)
6.2 Global Bioengineered Protein Drugs Revenue by Application (2017-2028)
6.3 Global Bioengineered Protein Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Bioengineered Protein Drugs Sales by Type (2017-2028)
7.2 North America Bioengineered Protein Drugs Sales by Application (2017-2028)
7.3 North America Bioengineered Protein Drugs Market Size by Country
7.3.1 North America Bioengineered Protein Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Bioengineered Protein Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Bioengineered Protein Drugs Sales by Type (2017-2028)
8.2 Europe Bioengineered Protein Drugs Sales by Application (2017-2028)
8.3 Europe Bioengineered Protein Drugs Market Size by Country
8.3.1 Europe Bioengineered Protein Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Bioengineered Protein Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Bioengineered Protein Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Bioengineered Protein Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Bioengineered Protein Drugs Market Size by Region
9.3.1 Asia-Pacific Bioengineered Protein Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Bioengineered Protein Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Bioengineered Protein Drugs Sales by Type (2017-2028)
10.2 South America Bioengineered Protein Drugs Sales by Application (2017-2028)
10.3 South America Bioengineered Protein Drugs Market Size by Country
10.3.1 South America Bioengineered Protein Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Bioengineered Protein Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bioengineered Protein Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Bioengineered Protein Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Bioengineered Protein Drugs Market Size by Country
11.3.1 Middle East & Africa Bioengineered Protein Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Bioengineered Protein Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Bioengineered Protein Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Bioengineered Protein Drugs
12.3 Bioengineered Protein Drugs Production Process
12.4 Bioengineered Protein Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Bioengineered Protein Drugs Typical Distributors
13.3 Bioengineered Protein Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Bioengineered Protein Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Bioengineered Protein Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Dr.Reddy’s Basic Information, Manufacturing Base and Competitors
Table 4. Dr.Reddy’s Major Business
Table 5. Dr.Reddy’s Bioengineered Protein Drugs Product and Services
Table 6. Dr.Reddy’s Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly Major Business
Table 9. Eli Lilly Bioengineered Protein Drugs Product and Services
Table 10. Eli Lilly Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Bioengineered Protein Drugs Product and Services
Table 14. Merck Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Reliance Life Sciences Basic Information, Manufacturing Base and Competitors
Table 16. Reliance Life Sciences Major Business
Table 17. Reliance Life Sciences Bioengineered Protein Drugs Product and Services
Table 18. Reliance Life Sciences Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Panacea Biotech Basic Information, Manufacturing Base and Competitors
Table 20. Panacea Biotech Major Business
Table 21. Panacea Biotech Bioengineered Protein Drugs Product and Services
Table 22. Panacea Biotech Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Bioengineered Protein Drugs Product and Services
Table 26. Novartis Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Fresenius Basic Information, Manufacturing Base and Competitors
Table 28. Fresenius Major Business
Table 29. Fresenius Bioengineered Protein Drugs Product and Services
Table 30. Fresenius Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Major Business
Table 33. Sanofi Bioengineered Protein Drugs Product and Services
Table 34. Sanofi Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. ProBioGen Basic Information, Manufacturing Base and Competitors
Table 36. ProBioGen Major Business
Table 37. ProBioGen Bioengineered Protein Drugs Product and Services
Table 38. ProBioGen Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 40. GlaxoSmithKline Major Business
Table 41. GlaxoSmithKline Bioengineered Protein Drugs Product and Services
Table 42. GlaxoSmithKline Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Roche Basic Information, Manufacturing Base and Competitors
Table 44. Roche Major Business
Table 45. Roche Bioengineered Protein Drugs Product and Services
Table 46. Roche Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Amoytop Biotech Basic Information, Manufacturing Base and Competitors
Table 48. Amoytop Biotech Major Business
Table 49. Amoytop Biotech Bioengineered Protein Drugs Product and Services
Table 50. Amoytop Biotech Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Shanghai United Cell Biotechnology Basic Information, Manufacturing Base and Competitors
Table 52. Shanghai United Cell Biotechnology Major Business
Table 53. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Product and Services
Table 54. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 56. Hualan Bio Major Business
Table 57. Hualan Bio Bioengineered Protein Drugs Product and Services
Table 58. Hualan Bio Bioengineered Protein Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Bioengineered Protein Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Bioengineered Protein Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Bioengineered Protein Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Bioengineered Protein Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Bioengineered Protein Drugs Production Site of Key Manufacturer
Table 64. Bioengineered Protein Drugs New Entrant and Capacity Expansion Plans
Table 65. Bioengineered Protein Drugs Mergers & Acquisitions in the Past Five Years
Table 66. Global Bioengineered Protein Drugs Sales by Region (2017-2022) & (K Units)
Table 67. Global Bioengineered Protein Drugs Sales by Region (2023-2028) & (K Units)
Table 68. Global Bioengineered Protein Drugs Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Bioengineered Protein Drugs Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Bioengineered Protein Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Global Bioengineered Protein Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Global Bioengineered Protein Drugs Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Bioengineered Protein Drugs Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Bioengineered Protein Drugs Price by Type (2017-2022) & (USD/Unit)
Table 75. Global Bioengineered Protein Drugs Price by Type (2023-2028) & (USD/Unit)
Table 76. Global Bioengineered Protein Drugs Sales by Application (2017-2022) & (K Units)
Table 77. Global Bioengineered Protein Drugs Sales by Application (2023-2028) & (K Units)
Table 78. Global Bioengineered Protein Drugs Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Bioengineered Protein Drugs Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Bioengineered Protein Drugs Price by Application (2017-2022) & (USD/Unit)
Table 81. Global Bioengineered Protein Drugs Price by Application (2023-2028) & (USD/Unit)
Table 82. North America Bioengineered Protein Drugs Sales by Country (2017-2022) & (K Units)
Table 83. North America Bioengineered Protein Drugs Sales by Country (2023-2028) & (K Units)
Table 84. North America Bioengineered Protein Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Bioengineered Protein Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Bioengineered Protein Drugs Sales by Type (2017-2022) & (K Units)
Table 87. North America Bioengineered Protein Drugs Sales by Type (2023-2028) & (K Units)
Table 88. North America Bioengineered Protein Drugs Sales by Application (2017-2022) & (K Units)
Table 89. North America Bioengineered Protein Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Europe Bioengineered Protein Drugs Sales by Country (2017-2022) & (K Units)
Table 91. Europe Bioengineered Protein Drugs Sales by Country (2023-2028) & (K Units)
Table 92. Europe Bioengineered Protein Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Bioengineered Protein Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Bioengineered Protein Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Europe Bioengineered Protein Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Europe Bioengineered Protein Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Europe Bioengineered Protein Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Bioengineered Protein Drugs Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Bioengineered Protein Drugs Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Bioengineered Protein Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Bioengineered Protein Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Bioengineered Protein Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Bioengineered Protein Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Bioengineered Protein Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Bioengineered Protein Drugs Sales by Application (2023-2028) & (K Units)
Table 106. South America Bioengineered Protein Drugs Sales by Country (2017-2022) & (K Units)
Table 107. South America Bioengineered Protein Drugs Sales by Country (2023-2028) & (K Units)
Table 108. South America Bioengineered Protein Drugs Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Bioengineered Protein Drugs Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Bioengineered Protein Drugs Sales by Type (2017-2022) & (K Units)
Table 111. South America Bioengineered Protein Drugs Sales by Type (2023-2028) & (K Units)
Table 112. South America Bioengineered Protein Drugs Sales by Application (2017-2022) & (K Units)
Table 113. South America Bioengineered Protein Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Bioengineered Protein Drugs Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Bioengineered Protein Drugs Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Bioengineered Protein Drugs Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Bioengineered Protein Drugs Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Bioengineered Protein Drugs Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Bioengineered Protein Drugs Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Bioengineered Protein Drugs Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Bioengineered Protein Drugs Sales by Application (2023-2028) & (K Units)
Table 122. Bioengineered Protein Drugs Raw Material
Table 123. Key Manufacturers of Bioengineered Protein Drugs Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Bioengineered Protein Drugs Typical Distributors
Table 127. Bioengineered Protein Drugs Typical Customers
List of Figures
Figure 1. Bioengineered Protein Drugs Picture
Figure 2. Global Bioengineered Protein Drugs Revenue Market Share by Type in 2021
Figure 3. Monoclonal Antibodies
Figure 4. Therapeutic Proteins
Figure 5. Vaccines
Figure 6. Global Bioengineered Protein Drugs Revenue Market Share by Application in 2021
Figure 7. Cancer
Figure 8. Diabetes
Figure 9. Autoimmune Disorder
Figure 10. Infectious Disease
Figure 11. Neurodegenerative
Figure 12. Others
Figure 13. Global Bioengineered Protein Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Bioengineered Protein Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Bioengineered Protein Drugs Sales (2017-2028) & (K Units)
Figure 16. Global Bioengineered Protein Drugs Price (2017-2028) & (USD/Unit)
Figure 17. Global Bioengineered Protein Drugs Production Capacity (2017-2028) & (K Units)
Figure 18. Global Bioengineered Protein Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Bioengineered Protein Drugs Market Drivers
Figure 20. Bioengineered Protein Drugs Market Restraints
Figure 21. Bioengineered Protein Drugs Market Trends
Figure 22. Global Bioengineered Protein Drugs Sales Market Share by Manufacturer in 2021
Figure 23. Global Bioengineered Protein Drugs Revenue Market Share by Manufacturer in 2021
Figure 24. Bioengineered Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Bioengineered Protein Drugs Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Bioengineered Protein Drugs Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Bioengineered Protein Drugs Sales Market Share by Region (2017-2028)
Figure 28. Global Bioengineered Protein Drugs Revenue Market Share by Region (2017-2028)
Figure 29. North America Bioengineered Protein Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Europe Bioengineered Protein Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Bioengineered Protein Drugs Revenue (2017-2028) & (USD Million)
Figure 32. South America Bioengineered Protein Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Bioengineered Protein Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Global Bioengineered Protein Drugs Sales Market Share by Type (2017-2028)
Figure 35. Global Bioengineered Protein Drugs Revenue Market Share by Type (2017-2028)
Figure 36. Global Bioengineered Protein Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 37. Global Bioengineered Protein Drugs Sales Market Share by Application (2017-2028)
Figure 38. Global Bioengineered Protein Drugs Revenue Market Share by Application (2017-2028)
Figure 39. Global Bioengineered Protein Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Bioengineered Protein Drugs Sales Market Share by Type (2017-2028)
Figure 41. North America Bioengineered Protein Drugs Sales Market Share by Application (2017-2028)
Figure 42. North America Bioengineered Protein Drugs Sales Market Share by Country (2017-2028)
Figure 43. North America Bioengineered Protein Drugs Revenue Market Share by Country (2017-2028)
Figure 44. United States Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Bioengineered Protein Drugs Sales Market Share by Type (2017-2028)
Figure 48. Europe Bioengineered Protein Drugs Sales Market Share by Application (2017-2028)
Figure 49. Europe Bioengineered Protein Drugs Sales Market Share by Country (2017-2028)
Figure 50. Europe Bioengineered Protein Drugs Revenue Market Share by Country (2017-2028)
Figure 51. Germany Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Bioengineered Protein Drugs Revenue Market Share by Region (2017-2028)
Figure 60. China Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Bioengineered Protein Drugs Sales Market Share by Type (2017-2028)
Figure 67. South America Bioengineered Protein Drugs Sales Market Share by Application (2017-2028)
Figure 68. South America Bioengineered Protein Drugs Sales Market Share by Country (2017-2028)
Figure 69. South America Bioengineered Protein Drugs Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Bioengineered Protein Drugs Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Bioengineered Protein Drugs Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Bioengineered Protein Drugs Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Bioengineered Protein Drugs Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Bioengineered Protein Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs in 2021
Figure 81. Manufacturing Process Analysis of Bioengineered Protein Drugs
Figure 82. Bioengineered Protein Drugs Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
